Foster Dykema Cabot & Co’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$17.5M Buy
136,034
+688
+0.5% +$91.3K 2.12% 18
2023
Q2
$18M Buy
135,346
+2,272
+2% +$300K 2.11% 19
2023
Q1
$17.2M Buy
133,074
+3,593
+3% +$469K 2.22% 19
2022
Q4
$17.6M Buy
129,481
+31,041
+32% +$4.11M 2.46% 15
2022
Q3
$11.9M Buy
+98,440
New +$12.7M 1.5% 20

Other funds holding XLV

Foster Dykema Cabot & Co's XLV Position: Q3 2023 in Review

Foster Dykema Cabot & Co increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 0.51% in Q3 2023, buying an estimated $91.3K and bringing the position to 136,034 shares worth $17.5M. The position accounts for 2.12% of the portfolio, ranked #18.

Foster Dykema Cabot & Co first reported a position in XLV in Q3 2022 and has held it in 5 quarters since. The position peaked at $18M in Q2 2023. 1,520 funds tracked by Wall St. Rank hold XLV as of Q3 2023.

  • Foster Dykema Cabot & Co held 136,034 shares of State Street Health Care Select Sector SPDR ETF worth $17.5M as of Q3 2023.
  • Foster Dykema Cabot & Co bought 688 State Street Health Care Select Sector SPDR ETF shares in Q3 2023, an estimated $91.3K.
  • State Street Health Care Select Sector SPDR ETF made up 2.12% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #18 holding.
  • Foster Dykema Cabot & Co first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2022 and has held it in 5 quarters since.
  • Foster Dykema Cabot & Co's State Street Health Care Select Sector SPDR ETF position peaked at $18M in Q2 2023.
  • 1,520 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.